Malignant mesothelioma with CD30-positivity: A case report and review of the literature

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 7, 2000, Pages 1077-1079

  Dunphy, Cherie H ^a,b   Gardner, Laura J ^a   Bee, Christopher S ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN;

AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CASE REPORT; HUMAN; IMMUNOBLAST; LYMPHOCYTE PROLIFERATION; MALE; MALIGNANT MESOTHELIOMA; MEMBRANE BINDING; PURKINJE CELL; REED STERNBERG CELL; T LYMPHOCYTE ACTIVATION;

AGED; ANTIGENS, CD30; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033867764     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H. Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood. 1989;74:1678-1689.
2. Schwarting R, Stein H. Cluster report: CD30. In: Knapp W, Dorken B, Gilks WR, et al, eds. Leucocyte Typing IV: White Cell Differentiation Antigens. New York, NY: Oxford University Press; 1989:419-422.
3. Van der Valk P, Mullink H, Huijgens PC, Tadema TM, Vos W, Meijer CJLM. Immunohistochemistry in bone marrow diagnosis: value of a panel of monoclonal antibodies on routinely processed bone marrow biopsies. Am J Surg Pathol. 1989;13:97-106.
4. Leoncini L, Del Vecchio MT, Kraft R, et al. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas-a continuous spectrum of malignant disorders: a quantitative morphometric and immunohistologic study. Am J Pathol. 1990;137:1047-1057.
5. Hall PA, D'Ardenne AJ, Stansfeld AC. Paraffin section immunohistochemistry, II: Hodgkin's disease and large cell anaplastic (Ki-1) lymphoma. Histopathology. 1988;13:161-169.
6. Casey TT, Olsen SJ, Cousar JB, Collins RD. Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's disease in plastic-embedded sections. Blood. 1989;74:2624-2628.
7. DeMascarel I, Trojani M, Eghbali H, Coindre JM, Bonichon F. Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin's disease. Arch Pathol Lab Med. 1990;114:953-955.
8. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytes. Am J Pathol. 1988;130:59-70.
9. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol. 1991;9:539-547.
10. Chittal SM, Caveriviere P, Schwarting P, et al. Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. Am J Surg Pathol. 1988;12:9-21.
11. Hall PA, D'Ardenne AJ, Stansfeld AC. Paraffin section immunohistochemistry, I: non-Hodgkin's lymphoma. Histopathology. 1988;13:149-160.
12. Norton AJ, Isaacson PC. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. Am J Pathol. 1987;128:225-240.
13. Hauschild A, Sterry W. Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas. Am J Pathol. 1989;135:177-184.
14. Piris M, Brown D, Gatter K, Mason D. CD30 expression in non-Hodgkin's lymphoma. Histopathology. 1990;17:211-218.
15. Piris M, Gatter K, Mason D. CD30 expression in follicular lymphoma. Histopathology. 1990;18:25-29.
16. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol. 1988;133:446-450.
17. Carson, F. Histotechnology, a Self Instructional Text. Chicago, Ill: ASCP Press; 1990:122-129.